New pill tested for schizophrenia symptoms
NCT ID NCT00862992
Summary
This study tested a new oral medication called MP-214 to see if it is safe and effective for people with schizophrenia. Thirty-four participants took one of three different doses of the pill daily for two weeks. The main goals were to check for side effects and to see how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hoyu Hospital
Kure, Hiroshima, Japan
Conditions
Explore the condition pages connected to this study.